Alumis Stock (NASDAQ: ALMS) stock price, news, charts, stock research, profile.
Open | $12.96 |
Close | $11.95 |
Volume / Avg. | 262.53K / 242.85K |
Day Range | 11.65 - 12.96 |
52 Wk Range | 10.45 - 13.53 |
Market Cap | $725.34M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 1.54% |
Days to Cover | 3.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alumis (NASDAQ:ALMS) through any online brokerage.
Other companies in Alumis’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and WAVE Life Sciences (NASDAQ:WVE).
There is no analysis for Alumis.
Alumis has a consensus price target of $32.33.
The stock price for Alumis (NASDAQ: ALMS) is $12.76 last updated July 29, 2024 at 6:44 PM EDT.
There are no upcoming dividends for Alumis.
Alumis’s Q2 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for Alumis.
Alumis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.